Sp1193
UNDERSTANDING HOW NEW TECHNOLOGY GETS A NEW CPT CODE AND VALUATION
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
This session will provide attendees with the knowledge and skills to successfully create and implement new technology into their practices through negotiation with payors and securing support from hospital systems. Learn from experts in reimbursement and insurance negotiation, hear from payors what makes a persuasive case to cover new technology and apply the concepts from this seminar to create a business plan for successful adoption of third space endoscopy.
This session will provide attendees with the knowledge and skills to successfully create and implement new technology into their practices through negotiation with payors and securing support from hospital systems. Learn from experts in reimbursement and insurance negotiation, hear from payors what makes a persuasive case to cover new technology and apply the concepts from this seminar to create a business plan for successful adoption of third space endoscopy.
Presenter
Massachusetts General Hospital
Tracks
Related Products
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
SMALL BOWEL POSTPRANDIAL RESPONSE IN FUNCTIONAL DYSPEPSIA COMPARED TO BLUNTED GASTROPARETICS AND HEALTHY SUBJECTS MEASURED BY WIRELESS MOTILITY CAPSULE
INTRODUCTION: Patients with upper gastrointestinal (UGI) symptoms of abdominal pain, nausea, vomiting, and bloating often complain within the postprandial period…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
